Combined toxic effects of aflatoxin B2 and the protective role of resveratrol in Swiss albino mice

Abstract In this study, the toxic effects of aflatoxin B 2 (AFB 2 ) on Swiss albino mice and the protective effects of resveratrol were investigated. Physiological (body weight, liver and kidney weight), biochemical (aspartate aminotransferase-AST, alanine transaminase-ALT, blood urea nitrogen-BUN,...

Full description

Saved in:
Bibliographic Details
Published inScientific reports Vol. 11; no. 1; pp. 1 - 14
Main Authors Gündüz, Alperen, Yalçın, Emine, Çavuşoğlu, Kültiğin
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group 10.09.2021
Nature Publishing Group UK
Nature Portfolio
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Abstract In this study, the toxic effects of aflatoxin B 2 (AFB 2 ) on Swiss albino mice and the protective effects of resveratrol were investigated. Physiological (body weight, liver and kidney weight), biochemical (aspartate aminotransferase-AST, alanine transaminase-ALT, blood urea nitrogen-BUN, creatinine, malondialdehyde-MDA and glutathione-GSH) and cytogenetic parameters (micronucleus-MN in buccal epithelium, erythrocyte and leukocyte cells and chromosomal aberrations-CAs) were used to determine the toxic effects. Additionally, scavenging effects of resveratrol against superoxide, hydrogen peroxide (H 2 O 2 ) and 1,1-diphenyl-2-picrylhydrazyl (DPPH) radicals were also investigated. In experimental period, mice were divided into six groups and the groups were treated with tap water, 10 mg/kg b.w resveratrol, 20 mg/kg b.w resveratrol, 20 µg/kg b.w. AFB 2 , 10 mg/kg b.w resveratrol + 20 µg/kg b.w AFB 2 , 20 mg/kg b.w resveratrol + 20 µg/kg b.w AFB 2 , respectively. As a result, the scavenging effects of resveratrol increased with increasing dose and the superoxide, H 2 O 2 and DPPH radical scavenging activity of resveratrol were 74.9%, 79.1% and 49.2%, respectively. AFB 2 administration caused a significant decrease in physiological parameters, and these decreases regressed in AFB 2  + resveratrol treated groups. Serum ALT and AST activities, BUN and creatinine levels were higher in the AFB 2 treated group compared to the control group and serious abnormalities were found in MDA and GSH levels in the kidney and liver. In the group treated with AFB 2  + 20 mg/kg resveratrol, ALT, AST, BUN and creatinine levels decreased significantly and GSH levels increased compared to only-AFB 2 treated group. AFB 2 triggered MN formation in buccal epithelium, erythrocyte and leukocyte cells and CAs in bone marrow cells. The application of 20 mg/kg resveratrol together with AFB 2 was decreased the MN and CAs frequency. Resveratrol exhibited a recovery effect in the range of 40.9–80.5% against AFB 2 toxicity in all tested parameters. In this study, it was determined that AFB 2 caused serious changes in selected physiological, biochemical and cytogenetic parameters while resveratrol displayed a protective role against these toxic effects.
AbstractList In this study, the toxic effects of aflatoxin B 2 (AFB 2 ) on Swiss albino mice and the protective effects of resveratrol were investigated. Physiological (body weight, liver and kidney weight), biochemical (aspartate aminotransferase-AST, alanine transaminase-ALT, blood urea nitrogen-BUN, creatinine, malondialdehyde-MDA and glutathione-GSH) and cytogenetic parameters (micronucleus-MN in buccal epithelium, erythrocyte and leukocyte cells and chromosomal aberrations-CAs) were used to determine the toxic effects. Additionally, scavenging effects of resveratrol against superoxide, hydrogen peroxide (H 2 O 2 ) and 1,1-diphenyl-2-picrylhydrazyl (DPPH) radicals were also investigated. In experimental period, mice were divided into six groups and the groups were treated with tap water, 10 mg/kg b.w resveratrol, 20 mg/kg b.w resveratrol, 20 µg/kg b.w. AFB 2 , 10 mg/kg b.w resveratrol + 20 µg/kg b.w AFB 2 , 20 mg/kg b.w resveratrol + 20 µg/kg b.w AFB 2 , respectively. As a result, the scavenging effects of resveratrol increased with increasing dose and the superoxide, H 2 O 2 and DPPH radical scavenging activity of resveratrol were 74.9%, 79.1% and 49.2%, respectively. AFB 2 administration caused a significant decrease in physiological parameters, and these decreases regressed in AFB 2  + resveratrol treated groups. Serum ALT and AST activities, BUN and creatinine levels were higher in the AFB 2 treated group compared to the control group and serious abnormalities were found in MDA and GSH levels in the kidney and liver. In the group treated with AFB 2  + 20 mg/kg resveratrol, ALT, AST, BUN and creatinine levels decreased significantly and GSH levels increased compared to only-AFB 2 treated group. AFB 2 triggered MN formation in buccal epithelium, erythrocyte and leukocyte cells and CAs in bone marrow cells. The application of 20 mg/kg resveratrol together with AFB 2 was decreased the MN and CAs frequency. Resveratrol exhibited a recovery effect in the range of 40.9–80.5% against AFB 2 toxicity in all tested parameters. In this study, it was determined that AFB 2 caused serious changes in selected physiological, biochemical and cytogenetic parameters while resveratrol displayed a protective role against these toxic effects.
Abstract In this study, the toxic effects of aflatoxin B 2 (AFB 2 ) on Swiss albino mice and the protective effects of resveratrol were investigated. Physiological (body weight, liver and kidney weight), biochemical (aspartate aminotransferase-AST, alanine transaminase-ALT, blood urea nitrogen-BUN, creatinine, malondialdehyde-MDA and glutathione-GSH) and cytogenetic parameters (micronucleus-MN in buccal epithelium, erythrocyte and leukocyte cells and chromosomal aberrations-CAs) were used to determine the toxic effects. Additionally, scavenging effects of resveratrol against superoxide, hydrogen peroxide (H 2 O 2 ) and 1,1-diphenyl-2-picrylhydrazyl (DPPH) radicals were also investigated. In experimental period, mice were divided into six groups and the groups were treated with tap water, 10 mg/kg b.w resveratrol, 20 mg/kg b.w resveratrol, 20 µg/kg b.w. AFB 2 , 10 mg/kg b.w resveratrol + 20 µg/kg b.w AFB 2 , 20 mg/kg b.w resveratrol + 20 µg/kg b.w AFB 2 , respectively. As a result, the scavenging effects of resveratrol increased with increasing dose and the superoxide, H 2 O 2 and DPPH radical scavenging activity of resveratrol were 74.9%, 79.1% and 49.2%, respectively. AFB 2 administration caused a significant decrease in physiological parameters, and these decreases regressed in AFB 2  + resveratrol treated groups. Serum ALT and AST activities, BUN and creatinine levels were higher in the AFB 2 treated group compared to the control group and serious abnormalities were found in MDA and GSH levels in the kidney and liver. In the group treated with AFB 2  + 20 mg/kg resveratrol, ALT, AST, BUN and creatinine levels decreased significantly and GSH levels increased compared to only-AFB 2 treated group. AFB 2 triggered MN formation in buccal epithelium, erythrocyte and leukocyte cells and CAs in bone marrow cells. The application of 20 mg/kg resveratrol together with AFB 2 was decreased the MN and CAs frequency. Resveratrol exhibited a recovery effect in the range of 40.9–80.5% against AFB 2 toxicity in all tested parameters. In this study, it was determined that AFB 2 caused serious changes in selected physiological, biochemical and cytogenetic parameters while resveratrol displayed a protective role against these toxic effects.
Abstract In this study, the toxic effects of aflatoxin B2 (AFB2) on Swiss albino mice and the protective effects of resveratrol were investigated. Physiological (body weight, liver and kidney weight), biochemical (aspartate aminotransferase-AST, alanine transaminase-ALT, blood urea nitrogen-BUN, creatinine, malondialdehyde-MDA and glutathione-GSH) and cytogenetic parameters (micronucleus-MN in buccal epithelium, erythrocyte and leukocyte cells and chromosomal aberrations-CAs) were used to determine the toxic effects. Additionally, scavenging effects of resveratrol against superoxide, hydrogen peroxide (H2O2) and 1,1-diphenyl-2-picrylhydrazyl (DPPH) radicals were also investigated. In experimental period, mice were divided into six groups and the groups were treated with tap water, 10 mg/kg b.w resveratrol, 20 mg/kg b.w resveratrol, 20 µg/kg b.w. AFB2, 10 mg/kg b.w resveratrol + 20 µg/kg b.w AFB2, 20 mg/kg b.w resveratrol + 20 µg/kg b.w AFB2, respectively. As a result, the scavenging effects of resveratrol increased with increasing dose and the superoxide, H2O2 and DPPH radical scavenging activity of resveratrol were 74.9%, 79.1% and 49.2%, respectively. AFB2 administration caused a significant decrease in physiological parameters, and these decreases regressed in AFB2 + resveratrol treated groups. Serum ALT and AST activities, BUN and creatinine levels were higher in the AFB2 treated group compared to the control group and serious abnormalities were found in MDA and GSH levels in the kidney and liver. In the group treated with AFB2 + 20 mg/kg resveratrol, ALT, AST, BUN and creatinine levels decreased significantly and GSH levels increased compared to only-AFB2 treated group. AFB2 triggered MN formation in buccal epithelium, erythrocyte and leukocyte cells and CAs in bone marrow cells. The application of 20 mg/kg resveratrol together with AFB2 was decreased the MN and CAs frequency. Resveratrol exhibited a recovery effect in the range of 40.9–80.5% against AFB2 toxicity in all tested parameters. In this study, it was determined that AFB2 caused serious changes in selected physiological, biochemical and cytogenetic parameters while resveratrol displayed a protective role against these toxic effects.
In this study, the toxic effects of aflatoxin B2 (AFB2) on Swiss albino mice and the protective effects of resveratrol were investigated. Physiological (body weight, liver and kidney weight), biochemical (aspartate aminotransferase-AST, alanine transaminase-ALT, blood urea nitrogen-BUN, creatinine, malondialdehyde-MDA and glutathione-GSH) and cytogenetic parameters (micronucleus-MN in buccal epithelium, erythrocyte and leukocyte cells and chromosomal aberrations-CAs) were used to determine the toxic effects. Additionally, scavenging effects of resveratrol against superoxide, hydrogen peroxide (H2O2) and 1,1-diphenyl-2-picrylhydrazyl (DPPH) radicals were also investigated. In experimental period, mice were divided into six groups and the groups were treated with tap water, 10 mg/kg b.w resveratrol, 20 mg/kg b.w resveratrol, 20 µg/kg b.w. AFB2, 10 mg/kg b.w resveratrol + 20 µg/kg b.w AFB2, 20 mg/kg b.w resveratrol + 20 µg/kg b.w AFB2, respectively. As a result, the scavenging effects of resveratrol increased with increasing dose and the superoxide, H2O2 and DPPH radical scavenging activity of resveratrol were 74.9%, 79.1% and 49.2%, respectively. AFB2 administration caused a significant decrease in physiological parameters, and these decreases regressed in AFB2 + resveratrol treated groups. Serum ALT and AST activities, BUN and creatinine levels were higher in the AFB2 treated group compared to the control group and serious abnormalities were found in MDA and GSH levels in the kidney and liver. In the group treated with AFB2 + 20 mg/kg resveratrol, ALT, AST, BUN and creatinine levels decreased significantly and GSH levels increased compared to only-AFB2 treated group. AFB2 triggered MN formation in buccal epithelium, erythrocyte and leukocyte cells and CAs in bone marrow cells. The application of 20 mg/kg resveratrol together with AFB2 was decreased the MN and CAs frequency. Resveratrol exhibited a recovery effect in the range of 40.9–80.5% against AFB2 toxicity in all tested parameters. In this study, it was determined that AFB2 caused serious changes in selected physiological, biochemical and cytogenetic parameters while resveratrol displayed a protective role against these toxic effects.
ArticleNumber 18081
Author Çavuşoğlu, Kültiğin
Yalçın, Emine
Gündüz, Alperen
Author_xml – sequence: 1
  givenname: Alperen
  surname: Gündüz
  fullname: Gündüz, Alperen
– sequence: 2
  givenname: Emine
  surname: Yalçın
  fullname: Yalçın, Emine
– sequence: 3
  givenname: Kültiğin
  surname: Çavuşoğlu
  fullname: Çavuşoğlu, Kültiğin
BookMark eNpVkctuFDEQRS2UiIQkP8DKEusGvx8bJBjxiBSJBcnaqnaXkx71tAe7ZwJ_jycTIeKN7fLxKZXuG3Iy5xkJecvZe86k-1AV1951TPDOa2d9Z1-Rc8GU7oQU4uS_8xm5qnXN2tLCK-5fkzOpNHOc63PSr_KmH2cc6JJ_j5FiShiXSnOikCY4FGf6WVCYG_GAdFvy0oBxj7TkCQ9cwbrHAku70wb_fBxrpTA1a6abMeIlOU0wVbx63i_I3dcvt6vv3c2Pb9erTzddlM7ZLvE09IOXiEINomdSMQuGa_QRAZUFEBwUEyiwtykm7bXxrk8-pp4P3MoLcn30DhnWYVvGDZQ_IcMYngq53AcoyxgnDFqY9g1MitqowSqnHRPWMQPRQTKsuT4eXdtdv8Eh4rwUmF5IX77M40O4z_vglJSKmyZ49ywo-dcO6xLWeVfmNn8Q2nKmhDGuUeJIxZJrLZj-deAsHGIOx5hDizk8xRys_Aunq5wF
CitedBy_id crossref_primary_10_3390_ijms25052849
crossref_primary_10_3389_fnut_2022_981984
crossref_primary_10_1038_s41598_022_18791_8
crossref_primary_10_1016_j_fct_2023_114120
crossref_primary_10_1038_s41598_023_41057_w
crossref_primary_10_1007_s11356_023_27436_w
crossref_primary_10_1007_s11356_023_30193_5
crossref_primary_10_1038_s41598_022_15800_8
crossref_primary_10_1038_s41598_022_20115_9
crossref_primary_10_1016_j_envres_2022_114183
crossref_primary_10_1038_s41598_023_28546_8
crossref_primary_10_1038_s41598_024_58338_7
crossref_primary_10_3390_ani11123516
crossref_primary_10_1007_s11356_021_17313_9
crossref_primary_10_1038_s41598_022_08421_8
crossref_primary_10_1007_s11356_024_33625_y
crossref_primary_10_1111_ijfs_17114
crossref_primary_10_1007_s00580_022_03413_6
Cites_doi 10.1016/j.bbadis.2011.03.008
10.1016/j.bbrc.2003.08.105
10.1016/j.foodchem.2007.09.073
10.1016/S1383-5742(01)00059-X
10.1016/j.prp.2014.06.001
10.1073/pnas.93.4.1535
10.1006/taap.1994.1148
10.1016/0165-1218(76)90031-8
10.1016/j.tox.2009.12.007
10.1111/j.1439-0507.1998.tb00384.x
10.1016/j.phrs.2005.08.002
10.1093/alcalc/agh256
10.1016/j.mrfmmm.2004.05.019
10.5772/52866
10.1016/0165-1218(85)90067-9
10.1016/S0300-483X(01)00471-1
10.5772/51201
10.1152/physrev.00018.2001
10.1016/B978-0-323-37101-8.00035-7
10.1016/j.neuropharm.2006.05.008
10.1046/j.1365-2362.2003.01219.x
10.1289/ehp.11667
10.1038/1811199a0
10.1016/j.livsci.2008.04.006
10.1016/0002-9378(79)90708-7
10.1016/j.fct.2014.12.003
10.5505/TurkHijyen.2012.54154
10.4315/0362-028X-64.3.379
10.1186/1550-2783-2-2-38
10.1016/0027-5107(73)90118-8
10.1067/mcp.2002.125975
10.1016/j.ifset.2009.07.002
10.1093/carcin/10.6.1003
10.1007/s10534-010-9329-x
10.1042/CS20120190
10.1056/NEJMra1100831
10.1016/S1386-6346(99)00085-6
10.1007/s11356-017-0232-7
10.1590/S0102-09352011000200031
10.1136/jmg.13.2.103
10.1016/S1383-5718(02)00249-8
10.1089/jmf.2013.2885
10.1007/s11356-019-06920-2
10.1080/713654953
10.1016/j.jaubas.2011.06.002
10.1080/13813455.2019.1648516
10.1093/toxsci/55.2.383
10.5152/tud.2017.34101
10.1016/S1383-5718(98)00053-9
10.1081/JDI-65221
10.1007/s00204-007-0262-x
10.1016/j.hepres.2006.02.005
10.1016/B978-0-12-228255-3.50010-6
10.2174/0929867043363721
ContentType Journal Article
Copyright The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2021
Copyright_xml – notice: The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2021
DBID AAYXX
CITATION
3V.
7X7
7XB
88A
88E
88I
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M2P
M7P
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
Q9U
5PM
DOA
DOI 10.1038/s41598-021-95879-7
DatabaseName CrossRef
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Biological Science Collection
Health & Medical Collection (Alumni Edition)
Medical Database
Science Database
Biological Science Database
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
Publicly Available Content Database
ProQuest Central Student
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Medical Library (Alumni)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest Central (Alumni)
DatabaseTitleList
CrossRef

Publicly Available Content Database
Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2045-2322
EndPage 14
ExternalDocumentID oai_doaj_org_article_5269cfa6fc564d74858027806ac8af60
10_1038_s41598_021_95879_7
GroupedDBID 0R~
3V.
4.4
53G
5VS
7X7
88A
88E
88I
8FE
8FH
8FI
8FJ
AAFWJ
AAJSJ
AAKDD
AAYXX
ABDBF
ABUWG
ACGFS
ACSMW
ADBBV
ADRAZ
AENEX
AFKRA
AFPKN
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
C6C
CCPQU
CITATION
DIK
DWQXO
EBD
EBLON
EBS
ESX
FYUFA
GNUQQ
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
KQ8
LK8
M0L
M1P
M2P
M48
M7P
M~E
NAO
OK1
PIMPY
PQQKQ
PROAC
PSQYO
RIG
RNT
RNTTT
RPM
SNYQT
UKHRP
7XB
8FK
K9.
PQEST
PQUKI
PRINS
Q9U
5PM
ID FETCH-LOGICAL-c3887-f1fdbd93ee24d2b03407a615e9ceae47aa21a402e2eb7fcf595698bf9cfb1d173
IEDL.DBID RPM
ISSN 2045-2322
IngestDate Fri Oct 04 13:12:56 EDT 2024
Tue Sep 17 21:25:51 EDT 2024
Fri Sep 13 10:21:54 EDT 2024
Fri Aug 23 02:03:25 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3887-f1fdbd93ee24d2b03407a615e9ceae47aa21a402e2eb7fcf595698bf9cfb1d173
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8433416/
PMID 34508115
PQID 2571042668
PQPubID 2041939
PageCount 14
ParticipantIDs doaj_primary_oai_doaj_org_article_5269cfa6fc564d74858027806ac8af60
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8433416
proquest_journals_2571042668
crossref_primary_10_1038_s41598_021_95879_7
PublicationCentury 2000
PublicationDate 20210910
PublicationDateYYYYMMDD 2021-09-10
PublicationDate_xml – month: 9
  year: 2021
  text: 20210910
  day: 10
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
PublicationTitle Scientific reports
PublicationYear 2021
Publisher Nature Publishing Group
Nature Publishing Group UK
Nature Portfolio
Publisher_xml – name: Nature Publishing Group
– name: Nature Publishing Group UK
– name: Nature Portfolio
References C Kerksick (95879_CR59) 2005; 2
M Theodotou (95879_CR71) 2019; 18
TS Nawrot (95879_CR56) 2008; 116
95879_CR6
MA Murcia (95879_CR36) 2001; 64
CL Do Amaral (95879_CR43) 2008; 82
BI Agag (95879_CR4) 2004; 7
Y Li (95879_CR21) 2006; 53
FY Özatik (95879_CR26) 2017; 43
95879_CR8
RJ Verma (95879_CR50) 1998; 26
M Fenech (95879_CR31) 2003; 534
RA Dimitri (95879_CR40) 1998; 41
P Palsamy (95879_CR52) 2011; 1812
G Yentür (95879_CR1) 2011; 69
A Kasdallah-Grissa (95879_CR58) 2006; 41
AA Kheir Eldin (95879_CR60) 2008; 7
P Larsson (95879_CR5) 2000; 55
JR Savage (95879_CR35) 1976; 13
TK Macar (95879_CR75) 2020; 27
M Kitada (95879_CR19) 2013; 124
FH Anderson (95879_CR45) 2000; 18
HM Shen (95879_CR57) 1994; 127
O Kovalchuk (95879_CR67) 1998; 415
İ Gülçin (95879_CR22) 2010; 11
MN Arvind (95879_CR39) 2015; 49
B Högstedt (95879_CR63) 1985; 156
T Yoshioka (95879_CR29) 1979; 135
E Jacotot (95879_CR54) 2000; 48
CM Stein (95879_CR14) 2002; 71
SM Jeon (95879_CR42) 2014; 17
E Beutler (95879_CR30) 1963; 61
95879_CR13
EA Bailey (95879_CR66) 1996; 93
A Cuypers (95879_CR55) 2010; 23
FP Guengerich (95879_CR65) 2001; 488
WH Butler (95879_CR25) 1969; 29
LA Corcuera (95879_CR64) 2015; 76
C Ara (95879_CR72) 2005; 27
S Şener (95879_CR2) 2006; 2
E Yalcin (95879_CR28) 2010; 19
MG Theumer (95879_CR20) 2010; 268
RJ Ruch (95879_CR23) 1989; 10
G Şener (95879_CR51) 2006; 35
S Gowda (95879_CR49) 2010; 2
L Guarente (95879_CR18) 2011; 364
VS Cardoso (95879_CR41) 2011; 63
GS Bbosa (95879_CR9) 2013
S Ide (95879_CR10) 2006; 51
95879_CR69
P Maier (95879_CR62) 1976; 40
MA Te-Hsiu (95879_CR33) 1995; 11
HS Hussein (95879_CR7) 2001; 167
G Eraslan (95879_CR46) 2017; 24
A Karaca (95879_CR44) 2019; 8
T Yurdun (95879_CR12) 1995; 31
K Cavusoglu (95879_CR27) 2010; 19
AM Bakeer (95879_CR48) 2013; 25
HA Fetaih (95879_CR68) 2014; 210
H Oguz (95879_CR37) 2000; 41
XY Han (95879_CR47) 2008; 119
AD Romano (95879_CR16) 2010; 23
W Droge (95879_CR15) 2002; 82
95879_CR38
MJ O’Riordan (95879_CR3) 2008; 107
95879_CR34
JK Kundu (95879_CR74) 2004; 555
CN Ezekiel (95879_CR53) 2011; 3
MS Blois (95879_CR24) 1958; 181
95879_CR70
SS Leonard (95879_CR17) 2003; 309
GA Losa (95879_CR73) 2003; 33
L Santana (95879_CR11) 2004; 11
B Taşlı (95879_CR32) 2015; 36
M Von Ledebur (95879_CR61) 1973; 19
References_xml – volume: 1812
  start-page: 719
  issue: 7
  year: 2011
  ident: 95879_CR52
  publication-title: Biochim. Biophys. Acta Mol. Basis Dis.
  doi: 10.1016/j.bbadis.2011.03.008
  contributor:
    fullname: P Palsamy
– volume: 309
  start-page: 1017
  issue: 4
  year: 2003
  ident: 95879_CR17
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2003.08.105
  contributor:
    fullname: SS Leonard
– volume: 107
  start-page: 1429
  issue: 4
  year: 2008
  ident: 95879_CR3
  publication-title: Food Chem.
  doi: 10.1016/j.foodchem.2007.09.073
  contributor:
    fullname: MJ O’Riordan
– volume: 31
  start-page: 11
  year: 1995
  ident: 95879_CR12
  publication-title: J. Fac. Pharm. Istanbul.
  contributor:
    fullname: T Yurdun
– volume: 488
  start-page: 195
  issue: 3
  year: 2001
  ident: 95879_CR65
  publication-title: Mutat. Res.
  doi: 10.1016/S1383-5742(01)00059-X
  contributor:
    fullname: FP Guengerich
– volume: 210
  start-page: 1079
  issue: 12
  year: 2014
  ident: 95879_CR68
  publication-title: Pathol. Res. Pract.
  doi: 10.1016/j.prp.2014.06.001
  contributor:
    fullname: HA Fetaih
– volume: 93
  start-page: 1535
  issue: 4
  year: 1996
  ident: 95879_CR66
  publication-title: PNAS
  doi: 10.1073/pnas.93.4.1535
  contributor:
    fullname: EA Bailey
– volume: 127
  start-page: 145
  issue: 1
  year: 1994
  ident: 95879_CR57
  publication-title: Toxicol. Appl. Pharmacol.
  doi: 10.1006/taap.1994.1148
  contributor:
    fullname: HM Shen
– volume: 40
  start-page: 325
  issue: 4
  year: 1976
  ident: 95879_CR62
  publication-title: Mutat. Res. Genet. Toxicol.
  doi: 10.1016/0165-1218(76)90031-8
  contributor:
    fullname: P Maier
– volume: 268
  start-page: 104
  issue: 1–2
  year: 2010
  ident: 95879_CR20
  publication-title: Toxicology
  doi: 10.1016/j.tox.2009.12.007
  contributor:
    fullname: MG Theumer
– volume: 19
  start-page: 2151
  issue: 10
  year: 2010
  ident: 95879_CR28
  publication-title: Fresenius Environ. Bull.
  contributor:
    fullname: E Yalcin
– volume: 41
  start-page: 87
  issue: 1–2
  year: 1998
  ident: 95879_CR40
  publication-title: Mycoses
  doi: 10.1111/j.1439-0507.1998.tb00384.x
  contributor:
    fullname: RA Dimitri
– volume: 53
  start-page: 6
  issue: 1
  year: 2006
  ident: 95879_CR21
  publication-title: Pharmacol. Res.
  doi: 10.1016/j.phrs.2005.08.002
  contributor:
    fullname: Y Li
– volume: 41
  start-page: 236
  issue: 3
  year: 2006
  ident: 95879_CR58
  publication-title: Alcohol Alcohol.
  doi: 10.1093/alcalc/agh256
  contributor:
    fullname: A Kasdallah-Grissa
– volume: 555
  start-page: 65
  issue: 1–2
  year: 2004
  ident: 95879_CR74
  publication-title: Mutat. Res. Fundum. Mol. Mech.
  doi: 10.1016/j.mrfmmm.2004.05.019
  contributor:
    fullname: JK Kundu
– ident: 95879_CR8
  doi: 10.5772/52866
– volume: 7
  start-page: 119
  year: 2008
  ident: 95879_CR60
  publication-title: Excli J.
  contributor:
    fullname: AA Kheir Eldin
– volume: 156
  start-page: 229
  year: 1985
  ident: 95879_CR63
  publication-title: Mutat. Res.
  doi: 10.1016/0165-1218(85)90067-9
  contributor:
    fullname: B Högstedt
– volume: 167
  start-page: 101
  issue: 2
  year: 2001
  ident: 95879_CR7
  publication-title: Toxicology
  doi: 10.1016/S0300-483X(01)00471-1
  contributor:
    fullname: HS Hussein
– volume: 29
  start-page: 2206
  issue: 12
  year: 1969
  ident: 95879_CR25
  publication-title: Cancer Res.
  contributor:
    fullname: WH Butler
– ident: 95879_CR38
– year: 2013
  ident: 95879_CR9
  publication-title: Aflatoxins Recent Adv. Future Prospects.
  doi: 10.5772/51201
  contributor:
    fullname: GS Bbosa
– volume: 82
  start-page: 47
  issue: 1
  year: 2002
  ident: 95879_CR15
  publication-title: Physiol. Rev.
  doi: 10.1152/physrev.00018.2001
  contributor:
    fullname: W Droge
– ident: 95879_CR34
– ident: 95879_CR69
  doi: 10.1016/B978-0-323-37101-8.00035-7
– volume: 19
  start-page: 2164
  issue: 10
  year: 2010
  ident: 95879_CR27
  publication-title: Fresenius Environ. Bull.
  contributor:
    fullname: K Cavusoglu
– volume: 26
  start-page: 427
  issue: 6
  year: 1998
  ident: 95879_CR50
  publication-title: Med. Sci. Res.
  contributor:
    fullname: RJ Verma
– volume: 7
  start-page: 173
  issue: 1
  year: 2004
  ident: 95879_CR4
  publication-title: Ass. Univ. Bull. Environ. Res.
  contributor:
    fullname: BI Agag
– volume: 51
  start-page: 651
  issue: 3
  year: 2006
  ident: 95879_CR10
  publication-title: Neuropharmacology
  doi: 10.1016/j.neuropharm.2006.05.008
  contributor:
    fullname: S Ide
– volume: 33
  start-page: 818
  issue: 9
  year: 2003
  ident: 95879_CR73
  publication-title: Eur. J. Clin. Investig.
  doi: 10.1046/j.1365-2362.2003.01219.x
  contributor:
    fullname: GA Losa
– volume: 49
  start-page: 658
  issue: 5
  year: 2015
  ident: 95879_CR39
  publication-title: Indian J. Anim. Res.
  contributor:
    fullname: MN Arvind
– volume: 25
  start-page: 29
  year: 2013
  ident: 95879_CR48
  publication-title: BVMJ.
  contributor:
    fullname: AM Bakeer
– volume: 2
  start-page: 135
  issue: 46
  year: 2006
  ident: 95879_CR2
  publication-title: Türkiye Klinikleri J. Surg. Med. Sci.
  contributor:
    fullname: S Şener
– volume: 116
  start-page: 1620
  issue: 12
  year: 2008
  ident: 95879_CR56
  publication-title: Environ. Health Perspect.
  doi: 10.1289/ehp.11667
  contributor:
    fullname: TS Nawrot
– volume: 181
  start-page: 1199
  year: 1958
  ident: 95879_CR24
  publication-title: Nature
  doi: 10.1038/1811199a0
  contributor:
    fullname: MS Blois
– volume: 119
  start-page: 216
  issue: 1–3
  year: 2008
  ident: 95879_CR47
  publication-title: Livest. Sci.
  doi: 10.1016/j.livsci.2008.04.006
  contributor:
    fullname: XY Han
– volume: 61
  start-page: 882
  year: 1963
  ident: 95879_CR30
  publication-title: J. Lab. Clin. Med.
  contributor:
    fullname: E Beutler
– volume: 135
  start-page: 372
  issue: 3
  year: 1979
  ident: 95879_CR29
  publication-title: Am. J. Obstet. Gynecol.
  doi: 10.1016/0002-9378(79)90708-7
  contributor:
    fullname: T Yoshioka
– volume: 76
  start-page: 116
  year: 2015
  ident: 95879_CR64
  publication-title: Food Chem. Toxicol.
  doi: 10.1016/j.fct.2014.12.003
  contributor:
    fullname: LA Corcuera
– volume: 2
  start-page: 170
  issue: 4
  year: 2010
  ident: 95879_CR49
  publication-title: N. Am. J. Med. Sci.
  contributor:
    fullname: S Gowda
– volume: 3
  start-page: 97
  issue: 2
  year: 2011
  ident: 95879_CR53
  publication-title: Arch. Appl. Sci. Res.
  contributor:
    fullname: CN Ezekiel
– volume: 69
  start-page: 41
  issue: 1
  year: 2011
  ident: 95879_CR1
  publication-title: Türk Hij. Den. Biyol. Derg.
  doi: 10.5505/TurkHijyen.2012.54154
  contributor:
    fullname: G Yentür
– volume: 64
  start-page: 379
  issue: 3
  year: 2001
  ident: 95879_CR36
  publication-title: J. Food Prot.
  doi: 10.4315/0362-028X-64.3.379
  contributor:
    fullname: MA Murcia
– volume: 2
  start-page: 38
  issue: 2
  year: 2005
  ident: 95879_CR59
  publication-title: J. Int. Soc. Sports Nutr.
  doi: 10.1186/1550-2783-2-2-38
  contributor:
    fullname: C Kerksick
– volume: 19
  start-page: 109
  issue: 1
  year: 1973
  ident: 95879_CR61
  publication-title: Mutat. Res. Fundum. Mol. Mech.
  doi: 10.1016/0027-5107(73)90118-8
  contributor:
    fullname: M Von Ledebur
– volume: 48
  start-page: 271
  issue: 3
  year: 2000
  ident: 95879_CR54
  publication-title: Pathol. Biol.
  contributor:
    fullname: E Jacotot
– volume: 71
  start-page: 411
  year: 2002
  ident: 95879_CR14
  publication-title: Cli. Pharmacol. Ther.
  doi: 10.1067/mcp.2002.125975
  contributor:
    fullname: CM Stein
– volume: 18
  start-page: 559
  issue: 1
  year: 2019
  ident: 95879_CR71
  publication-title: Exp. Ther. Med.
  contributor:
    fullname: M Theodotou
– volume: 11
  start-page: 210
  issue: 1
  year: 2010
  ident: 95879_CR22
  publication-title: Innov. Food Sci. Emerg. Technol.
  doi: 10.1016/j.ifset.2009.07.002
  contributor:
    fullname: İ Gülçin
– volume: 36
  start-page: 63
  issue: 2
  year: 2015
  ident: 95879_CR32
  publication-title: Cumhuriyet Sci. J.
  contributor:
    fullname: B Taşlı
– volume: 10
  start-page: 1003
  year: 1989
  ident: 95879_CR23
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/10.6.1003
  contributor:
    fullname: RJ Ruch
– volume: 23
  start-page: 927
  issue: 5
  year: 2010
  ident: 95879_CR55
  publication-title: Biometals
  doi: 10.1007/s10534-010-9329-x
  contributor:
    fullname: A Cuypers
– volume: 11
  start-page: 95
  year: 1995
  ident: 95879_CR33
  publication-title: Rev. Int. Contam. Ambient.
  contributor:
    fullname: MA Te-Hsiu
– volume: 124
  start-page: 153
  issue: 3
  year: 2013
  ident: 95879_CR19
  publication-title: Clin. Sci.
  doi: 10.1042/CS20120190
  contributor:
    fullname: M Kitada
– volume: 364
  start-page: 2235
  issue: 23
  year: 2011
  ident: 95879_CR18
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMra1100831
  contributor:
    fullname: L Guarente
– volume: 18
  start-page: 63
  issue: 1
  year: 2000
  ident: 95879_CR45
  publication-title: Hepatol. Res.
  doi: 10.1016/S1386-6346(99)00085-6
  contributor:
    fullname: FH Anderson
– volume: 24
  start-page: 27931
  issue: 36
  year: 2017
  ident: 95879_CR46
  publication-title: Environ. Sci. Pollut. Res.
  doi: 10.1007/s11356-017-0232-7
  contributor:
    fullname: G Eraslan
– volume: 63
  start-page: 495
  issue: 2
  year: 2011
  ident: 95879_CR41
  publication-title: Arq. Bras. Med. Vet. Zootec.
  doi: 10.1590/S0102-09352011000200031
  contributor:
    fullname: VS Cardoso
– volume: 13
  start-page: 103
  year: 1976
  ident: 95879_CR35
  publication-title: J. Med. Genet.
  doi: 10.1136/jmg.13.2.103
  contributor:
    fullname: JR Savage
– ident: 95879_CR13
– volume: 23
  start-page: 29
  year: 2010
  ident: 95879_CR16
  publication-title: J. Nephrol.
  contributor:
    fullname: AD Romano
– volume: 534
  start-page: 65
  issue: 1
  year: 2003
  ident: 95879_CR31
  publication-title: Mutat. Res. Genet. Toxicol. Environ. Mutagen.
  doi: 10.1016/S1383-5718(02)00249-8
  contributor:
    fullname: M Fenech
– volume: 17
  start-page: 310
  issue: 3
  year: 2014
  ident: 95879_CR42
  publication-title: J. Med. Food.
  doi: 10.1089/jmf.2013.2885
  contributor:
    fullname: SM Jeon
– volume: 27
  start-page: 657
  issue: 1
  year: 2020
  ident: 95879_CR75
  publication-title: Environ. Sci. Pollut. Res.
  doi: 10.1007/s11356-019-06920-2
  contributor:
    fullname: TK Macar
– volume: 41
  start-page: 512
  issue: 4
  year: 2000
  ident: 95879_CR37
  publication-title: Br. Poult. Sci.
  doi: 10.1080/713654953
  contributor:
    fullname: H Oguz
– ident: 95879_CR70
  doi: 10.1016/j.jaubas.2011.06.002
– volume: 8
  start-page: 1
  issue: 5
  year: 2019
  ident: 95879_CR44
  publication-title: Arch. Physiol. Biochem.
  doi: 10.1080/13813455.2019.1648516
  contributor:
    fullname: A Karaca
– volume: 55
  start-page: 383
  year: 2000
  ident: 95879_CR5
  publication-title: Toxicol. Sci.
  doi: 10.1093/toxsci/55.2.383
  contributor:
    fullname: P Larsson
– volume: 43
  start-page: 444
  issue: 4
  year: 2017
  ident: 95879_CR26
  publication-title: Turk. J. Urol.
  doi: 10.5152/tud.2017.34101
  contributor:
    fullname: FY Özatik
– volume: 415
  start-page: 47
  year: 1998
  ident: 95879_CR67
  publication-title: Mutat. Res.
  doi: 10.1016/S1383-5718(98)00053-9
  contributor:
    fullname: O Kovalchuk
– volume: 27
  start-page: 435
  issue: 4
  year: 2005
  ident: 95879_CR72
  publication-title: Ren. Fail.
  doi: 10.1081/JDI-65221
  contributor:
    fullname: C Ara
– volume: 82
  start-page: 363
  issue: 6
  year: 2008
  ident: 95879_CR43
  publication-title: Arch. Toxicol.
  doi: 10.1007/s00204-007-0262-x
  contributor:
    fullname: CL Do Amaral
– volume: 35
  start-page: 62
  issue: 1
  year: 2006
  ident: 95879_CR51
  publication-title: Hepatol. Res.
  doi: 10.1016/j.hepres.2006.02.005
  contributor:
    fullname: G Şener
– ident: 95879_CR6
  doi: 10.1016/B978-0-12-228255-3.50010-6
– volume: 11
  start-page: 3239
  issue: 24
  year: 2004
  ident: 95879_CR11
  publication-title: Curr. Med. Chem.
  doi: 10.2174/0929867043363721
  contributor:
    fullname: L Santana
SSID ssj0000529419
Score 2.4298747
Snippet Abstract In this study, the toxic effects of aflatoxin B 2 (AFB 2 ) on Swiss albino mice and the protective effects of resveratrol were investigated....
In this study, the toxic effects of aflatoxin B2 (AFB2) on Swiss albino mice and the protective effects of resveratrol were investigated. Physiological (body...
In this study, the toxic effects of aflatoxin B 2 (AFB 2 ) on Swiss albino mice and the protective effects of resveratrol were investigated. Physiological...
Abstract In this study, the toxic effects of aflatoxin B2 (AFB2) on Swiss albino mice and the protective effects of resveratrol were investigated....
SourceID doaj
pubmedcentral
proquest
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
StartPage 1
SubjectTerms Aflatoxins
Alanine
Alanine transaminase
Albinism
Aspartate aminotransferase
Body weight
Bone marrow
Chromosome aberrations
Creatinine
Cytogenetics
Drinking water
Epithelium
Erythrocytes
Glutathione
Hydrogen peroxide
Kidneys
Liver
Malondialdehyde
Physiology
Resveratrol
Superoxide
Toxicity
Transaminase
Urea
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LSxxBEG6CIOQSoknIxlX6kFsYnH5MP44qigjJJRG8Nf2oRkFmQ1xN_PdWzYxh5-TF4_QUM81X_aiPrq6Psa-pg7YqWxrpwTVapLZJSpbGR9BZeZftoN7w_Yc5v9QXV93VhtQX5YSN5YFH4A5JATvXaGrujC5Wu87RYVlrYnaxmpGti26DTI1VvaXXwk-3ZFrlDu9wp6LbZJSR0DnrGzvbiYaC_bMoc54jubHpnL1n76ZokR-Nvdxhb6DfZdujfuTjB5ZwNiOzhcLXq383mU_JGXxVeay3kRp7fix57NHiGvhUlAEXOE5ZhWSHbPuB6irjM0fjn3_RETze4ldXnJTqP7LLs9NfJ-fNJJrQZEULRhW1pOIVgNRFplYhY4sYtoDPgPjbGKWISBpBQrI11w4JknepIshJFGHVJ7bVr3r4zLgk2XQMIFNNVntRvDQgO7DKOBFjhgX79gxg-D3WxgjDmbZyYYQ7INxhgDvYBTsmjP9bUl3roQG9HSZvh5e8vWDLZw-FabLdBVx1BFFB4xbMzrw2-9n8TX9zPRTTdlrhRm6-vEbv9thbSQOMFCbaJdta_7mHfYxZ1ulgGJ5PPoHp_w
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LaxRBEC5iRPAi8YWrUfrgTYadfkw_TpKIYRH0ooG9Nf00gTATkzXRf2_V7Gx0Lh5npuiBqup6dFXXB_A2dqWt0uRGuGIbxWPbRCly40JRSTqbzIje8PmLXp2qT-tuvQer3V0Yaqvc2cTRUOch0Rn5ElWLU7yv7TJEOgVIm-X7yx8N4UdRnXUC07gH97nAsAI126zN3WkL1bMUd9OtmVba5TV6LrpdRh0KnTWuMTPPNA7wn0Wd857Jf5zQyQE8mqJHdrQV92PYK_0TeLDFk_z9FCLubsx0S2ab4dd5YlOzBhsqC_Ui0MueHQsWeqQ4K2wa0oAGj1GXIdFh9n1Dc5bxmSHx11sUDAsXuOrACLn-GZyefPz2YdVMIApNkmRAKq85ZidLESqL2ErM4AKGMcWlgvIwIQgeMIksokRTU-0wYXI2Vpdq5Jkb-Rz2-6EvL4AJglHHgDLWaJTj2QldRFeM1JaHkMoC3u0Y6C-3szL8WOOW1m_Z7ZHdfmS3Nws4Jh7fUdKc6_HFcPXdT9vGE_55qkHX1GmVjbKdpVJpq0Oyoep2AYc7Cflp8137v6qyADOT2uxn8y_9-dk4XNsqiY5dv_z_wq_goSDVISyJ9hD2N1c_y2uMTjbxzah4fwCIj-W9
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Open Access Journals
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3NaxUxEA-1IngRP_FpKzl4k9XdJJuPQylWLEWoF33QW8jHxBYeu_X1qe1_78zuvuJCLx43O2TZmUlmhkx-P8bexhbqIk2uhANbqSbWVZQiVy6AStLZZAb2htOv-mSpvpy1ZztsS3c0KfDqztKO-KSW69X76583h7jgD8Yr4_bDFQYhuihGzQatNa4y99h9oaQijz-d0v0R61s4NXB9EAh7hcmEmO7R3D3NLFYNkP6zPHTeRflPWDp-zB5N-ST_ODrAE7YD3VP2YGSYvHnGIq53rH0h801_fZH41L7B-8JDWQUa7PiR4KFDiXPgE2wDboGc-g5JDuvx34S8jM8chb_9QVPxsMJZe05c9s_Z8vjz908n1USrUCVJW0ppSo7ZSQChsoi1xJouYGIDLgFayIQgmoBlJQiIpqTSYgnlbCwuldjkxsgXbLfrO3jJuCBidUwxY4lGuSY7oUG0YKS2TQgJFuzdVoH-ckTP8MOpt7R-VLdHdftB3d4s2BHp-FaSkK-HgX79w08LyRMjeipBl9RqlY2yraXD01qHZEPR9YLtbS3kt97kcV9qqFjUdsHMzGqzj83fdBfnA9y2VRJDvX71X__ymj0U5ElENlHvsd3N-hfsY_qyiW8Gn_wL4lXrBw
  priority: 102
  providerName: Scholars Portal
Title Combined toxic effects of aflatoxin B2 and the protective role of resveratrol in Swiss albino mice
URI https://www.proquest.com/docview/2571042668/abstract/
https://pubmed.ncbi.nlm.nih.gov/PMC8433416
https://doaj.org/article/5269cfa6fc564d74858027806ac8af60
Volume 11
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Za9wwEBY5KPSlND3otumih74VZ63DOh67ISEENoS0gX0TOpuFjR2S7fXvO5K9Zf3aF4Pt8cHMaDQfGs2H0CfXxDoxGSqqo6o4cXXlGA2VtpF7ppWXhb1hcSUubvnlslnuoWa7F6YU7Xu3OmnX9yft6q7UVj7c-9m2Tmx2vThVnEHwFbN9tC8Z24HofUNvqjnRwwaZmqnZE0xSeSNZLkZolNRVZt5jHFITktlwd-aj0rZ_lGuOKyV3pp7zl-jFkDPiL_2_HaG92L5Cz3oWyT-vkYMxDfg2Brzpfq88Hko0cJewTWubL7Z4TrFtQeIu4qE1A4Q5nGsLsxxg7p-5uzKcYxD--gvMge0a3trhzFf_Bt2en307vagG6oTKsxw2EknBBc1ipDxQVzPAbRaSl6h9BCtIaymxAB0jjU4mnxqASVq5pH1yJBDJ3qKDtmvjO4RpJk-HNNIlJ7kmQVMRaRMlE4pY6-MEfd4q0Dz0HTJMWdlmyvSaN6B5UzRv5ATNs47_Sebu1uVC9_jdDDY2mfXcJyuSbwQPkqtG5QXSWlivbBL1BB1vLWSGIfdkIPaQDAiFmiA5stroY-M74GGlpfbgUe__-8kP6DnNDpbJJepjdLB5_BE_QrqycVNw0qWcosP52dX1zbSAfjguuJoWx_0LvnvvQw
link.rule.ids 230,315,733,786,790,870,891,2115,12083,21416,24346,27957,27958,31754,33779,43345,43840,53827,53829,74102,74659
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LbxQxDI6gCMGl4imWFsiBGxp18pg8TogiqgXaXmilvUV50krVTOkutPx77NlsYS4cJ2Mlku04duz4I-Rt6HJbhE4Nt9k0koW2CYKnxvoso7Am6hG94ehYzU_ll0W3qBduy1pWubGJo6FOQ8Q78j1QLYb-vjLvL380iBqF2dUKoXGX3JNCSCzp0wt9e8eCWSzJbH0r0wqzt4TzCt-UYV1CZ7Rt9OQ8Gtv2T3zNaaXkP0fPwSOyXX1G-mEt5MfkTu6fkPtrFMnfT0mAPQ3xbU50NdycR1pLNOhQqC8XHgd7us-p74HiLNPamgHMHMXaQqSDmPsXdleGbwrE365BHNRfwKwDRbz6Z-T04NPJx3lToROaKNBsFFZSSFbkzGXioRUQt3lwXrKNGaSgvefMQ-iYeQ66xNJBmGRNKDaWwBLT4jnZ6oc-vyCUI3g6uJGhBC0tS5arzLushTLM-5hn5N2Gge5y3SHDjZltYdya3Q7Y7UZ2Oz0j-8jjW0rsbj0ODFffXd0sDlHPY_GqxE7JpKXpDCZIW-Wj8UW1M7K7kZCrW27p_irIjOiJ1CaLTf_052djS22D6sPUy_9P_IY8mJ8cHbrDz8dfd8hDjmqEaBLtLtlaXf3Mr8A_WYXXoxL-AXBE5PA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagFYhLVV5ioYAP3FC0ie34cUIsdFVeqwqo1JvlZ1upSkp3gfbfM5P1FnLhGGfkSDPjeWTG8xHyyrepzlzFipmkK9H4uvKcxcq4JAI3OqgBveHLQh4ciY_H7XHpf1qWtsqNTRwMdewD_iOfgmo1GO9LPc2lLeLw_fzNxY8KEaSw0lrgNG6TbSVkCxq-PdtfHH69-eOCNS3RmHJzpuZ6ugTvhTfMsEuh1cpUauSdhiH-o8hz3Df5jyOa75KdEkHSt2uR3ye3UveA3FljSl4_JB5OOGS7KdJVf3UWaGnYoH2mLp87XOzojFHXAcVpomVQAxg9ip2GSAcZ-C-ctQzPFIi__QbhUHcOu_YU0esfkaP5_vd3B1UBUqgCRyOSmxx9NDwlJiLzNYcszkEok0xIIBPlHGscJJKJJa9yyC0kTUb7bEL2TWwUf0y2ur5LTwhlCKUOQaXPXgnTRMNkYm1SXOrGuZAm5PWGgfZiPS_DDnVuru2a3RbYbQd2WzUhM-TxDSXOuh4W-ssTW46ORQz0kJ3MoZUiKqFbjeXSWrqgXZb1hOxtJGTLAVzav-oyIWoktdHHxm-6s9NhwLYWHJy7fPr_jV-Su6CB9vOHxadn5B5DLUJoiXqPbK0uf6bnEKys_IuihX8AAizqkw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Combined+toxic+effects+of+aflatoxin+B2+and+the+protective+role+of+resveratrol+in+Swiss+albino+mice&rft.jtitle=Scientific+reports&rft.au=G%C3%BCnd%C3%BCz%2C+Alperen&rft.au=Yal%C3%A7%C4%B1n%2C+Emine&rft.au=%C3%87avu%C5%9Fo%C4%9Flu%2C+K%C3%BClti%C4%9Fin&rft.date=2021-09-10&rft.issn=2045-2322&rft.eissn=2045-2322&rft.volume=11&rft.issue=1&rft_id=info:doi/10.1038%2Fs41598-021-95879-7&rft.externalDBID=n%2Fa&rft.externalDocID=10_1038_s41598_021_95879_7
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-2322&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-2322&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-2322&client=summon